Sfoglia per Rivista
CD34-positive cells: biology and clinical relevance.
1995-01-01 CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S.
Cell cycle analysis in the diagnosis of Fanconi\'s anemia
2000-01-01 TIMEUS F; CRESCENZIO N; SARACCO P; LEONE L; PONZIO G; U. RAMENGHI
Cell surface markers and kinetic features in acute lymphoblastic leukaemia.
1981-01-01 CALIGARIS CAPPIO F ;NOVARINO A ;MATERA L ;GAVOSTO F
CFU-C and prognosis in a case of posthepatitic aplastic anaemia.
1978-01-01 MASERA P ;AGLIETTA M ;FOÀ R
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia
2009-01-01 Dufour C, Ferretti E, Bagnasco F, Burlando O, Lanciotti M, Ramenghi U, Saracco P, Van Lint MT, Longoni D, Torelli GF, Pillon M, Locasciulli A, Misuraca A, La Spina M, Bacigalupo A, Pistoia V, Corcione A, Svahn J; Marrow Failure Study Group of the AIEOP
Changes in lymphocyte subsets, angiogenic factors and plasma cytokines in patients with chronic lymphocytic leukemia during treatment with Ofatumumab and Lenalidomide
2015-01-01 Vitale C, ten Hacken E, Gao H, Keating MJ, O’Brien S, Wierda WG, Falchi L, Reuben J, Burger JA, Calin G, Ferrajoli A
CHARLSON COMORBIDITIES INDEX (CCI) MAY PREDICT COMPLIANCE AND DEVELOPMENT OF PLEURAL EFFUSIONS IN ELDERLY CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT PATIENTS TREATED WITH DASATINIB
2010-01-01 Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F;Ulisciani S;Cavazzini F;Annunziata M;Sorà F;Russo Rossi A; Pregno P; Porrini R; Abruzzese E; Giai V; Musto P;Tiribelli M; Binotto G; Occhini U; Vallone R; Martino B; Capodanno I; Spina F;Pane F; Santini V; Rosti G; Fava C; Alimena G
Charlson comorbidity index and adult comorbidity evaluation-27 might predict compliance and development of pleural effusions in elderly chronic myeloid leukemia patients treated with dasatinib after resistance/intolerance to imatinib.
2011-01-01 Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F; Fava C; Cavazzini F; Annunziata M; Russo Rossi A; Pregno P; Abruzzese E; Vigneri P; Rege-Cambrin G; Sica S; Pane F; Santini V; Specchia G; Rosti G; Alimena G
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification
2017-01-01 Laurenti, Luca*; Innocenti, Idanna; Autore, Francesco; Ciolli, Stefania; Mauro, Francesca Romana; Mannina, Donato; Del Poeta, Giovanni; D’Arena, Giovanni; Massaia, Massimo; Coscia, Marta; Molica, Stefano; Pozzato, Gabriele; Efremov, Dimitar G.; Vannata, Barbara; Marasca, Roberto; Galieni, Pietro; Cuneo, Antonio; Orlando, Sonia; Piciocchi, Alfonso; Boncompagni, Riccardo; Vincelli, Donatella; Liberati, Anna Marina; Russo, Filomena; Foa, Robin
CHROMOSOMAL ABNORMALITIES AND IMMUNOPHENOTYPE IN ELDERLY MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS ENTERED IN A PROSPECTIVE RANDOMIZED TRIAL OF VELCADE-MELPHALAN-PREDNISONE AND THALIDOMIDE VS VELCADE-MELPHALAN-PREDNISONE
2010-01-01 Caltagirone S;Ruggeri M;Gilestro M;Aschero S;Gambella M;Rocci A;Nozzoli C;Ria R;Rossi D;Bruno B;Palumbo A;Omede’ P;Boccadoro M
CHROMOSOMAL ABNORMALITIES IN MULTIPLE MYELOMA PLASMA CELLS AND THEIR CORRELATION WITH IMMUNOPHENOTYPE
2006-01-01 Omedè P; Ruggeri M; Brunetti M; Caltagirone S; Bringhen S; Gilestro M; Ferro F; Spagnolo M; Di Bello C; Bruno B; Palumbo A; Petrucci MT; Bertola A; Liberati AM; Boccadoro M
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA
2007-01-01 P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Liberati; M. Boccadoro
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA
2007-01-01 P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Leberati; M. Boccadoro
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies.
2014-01-01 Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omede' P.
Chromosome studies of enriched blast cell fractions in myelodysplastic syndromes terminating in acute myeloid leukemia
1990-01-01 Piva, N; Cuneo, A; Carli, M G; Cariani, D; Fagioli, F; Castoldi, G
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation
2009-01-01 Deaglio S; Malavasi F
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET
2016-01-01 Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S
Chronic myeloid leukemia: Reminiscences and dreams
2016-01-01 Mughal, Tariq I.; Radich, Jerald P.; Deininger, Michael W.; Apperley, Jane F.; Hughes, Timothy P.; Harrison, Christine J.; Gambacorti-passerini, Carlo; Saglio, Giuseppe; Cortes, Jorge; Daley, George Q.
Chronic myeloid leukemia: Room for improvement?
2017-01-01 Baccarani, Michele; Pane, Fabrizio; Rosti, Gianantonio; Russo, Domenico; Saglio, Giuseppe
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib
2012-01-01 White DL; Radich J; Soverini S; Saunders VA; Frede AK; Dang P; Cilloni D; Lin P; Mongay L; Woodman R; Manley P; Slader C; Kim DW; Pane F; Martinelli G; Saglio G; Hughes TP.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
CD34-positive cells: biology and clinical relevance. | 1995 | CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S. | |
Cell cycle analysis in the diagnosis of Fanconi\'s anemia | 2000 | TIMEUS F; CRESCENZIO N; SARACCO P; LEONE L; PONZIO G; U. RAMENGHI | |
Cell surface markers and kinetic features in acute lymphoblastic leukaemia. | 1981 | CALIGARIS CAPPIO F ;NOVARINO A ;MATERA L ;GAVOSTO F | |
CFU-C and prognosis in a case of posthepatitic aplastic anaemia. | 1978 | MASERA P ;AGLIETTA M ;FOÀ R | |
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia | 2009 | Dufour C, Ferretti E, Bagnasco F, Burlando O, Lanciotti M, Ramenghi U, Saracco P, Van Lint MT, Longoni D, Torelli GF, Pillon M, Locasciulli A, Misuraca A, La Spina M, Bacigalupo A, Pistoia V, Corcione A, Svahn J; Marrow Failure Study Group of the AIEOP | |
Changes in lymphocyte subsets, angiogenic factors and plasma cytokines in patients with chronic lymphocytic leukemia during treatment with Ofatumumab and Lenalidomide | 2015 | Vitale C, ten Hacken E, Gao H, Keating MJ, O’Brien S, Wierda WG, Falchi L, Reuben J, Burger JA, Calin G, Ferrajoli A | |
CHARLSON COMORBIDITIES INDEX (CCI) MAY PREDICT COMPLIANCE AND DEVELOPMENT OF PLEURAL EFFUSIONS IN ELDERLY CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT PATIENTS TREATED WITH DASATINIB | 2010 | Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F;Ulisciani S;Cavazzini F;Annunziata M;Sorà F;Russo Rossi A; Pregno P; Porrini R; Abruzzese E; Giai V; Musto P;Tiribelli M; Binotto G; Occhini U; Vallone R; Martino B; Capodanno I; Spina F;Pane F; Santini V; Rosti G; Fava C; Alimena G | |
Charlson comorbidity index and adult comorbidity evaluation-27 might predict compliance and development of pleural effusions in elderly chronic myeloid leukemia patients treated with dasatinib after resistance/intolerance to imatinib. | 2011 | Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F; Fava C; Cavazzini F; Annunziata M; Russo Rossi A; Pregno P; Abruzzese E; Vigneri P; Rege-Cambrin G; Sica S; Pane F; Santini V; Specchia G; Rosti G; Alimena G | |
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification | 2017 | Laurenti, Luca*; Innocenti, Idanna; Autore, Francesco; Ciolli, Stefania; Mauro, Francesca Romana; Mannina, Donato; Del Poeta, Giovanni; D’Arena, Giovanni; Massaia, Massimo; Coscia, Marta; Molica, Stefano; Pozzato, Gabriele; Efremov, Dimitar G.; Vannata, Barbara; Marasca, Roberto; Galieni, Pietro; Cuneo, Antonio; Orlando, Sonia; Piciocchi, Alfonso; Boncompagni, Riccardo; Vincelli, Donatella; Liberati, Anna Marina; Russo, Filomena; Foa, Robin | |
CHROMOSOMAL ABNORMALITIES AND IMMUNOPHENOTYPE IN ELDERLY MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS ENTERED IN A PROSPECTIVE RANDOMIZED TRIAL OF VELCADE-MELPHALAN-PREDNISONE AND THALIDOMIDE VS VELCADE-MELPHALAN-PREDNISONE | 2010 | Caltagirone S;Ruggeri M;Gilestro M;Aschero S;Gambella M;Rocci A;Nozzoli C;Ria R;Rossi D;Bruno B;Palumbo A;Omede’ P;Boccadoro M | |
CHROMOSOMAL ABNORMALITIES IN MULTIPLE MYELOMA PLASMA CELLS AND THEIR CORRELATION WITH IMMUNOPHENOTYPE | 2006 | Omedè P; Ruggeri M; Brunetti M; Caltagirone S; Bringhen S; Gilestro M; Ferro F; Spagnolo M; Di Bello C; Bruno B; Palumbo A; Petrucci MT; Bertola A; Liberati AM; Boccadoro M | |
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA | 2007 | P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Liberati; M. Boccadoro | |
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA | 2007 | P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Leberati; M. Boccadoro | |
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. | 2014 | Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omede' P. | |
Chromosome studies of enriched blast cell fractions in myelodysplastic syndromes terminating in acute myeloid leukemia | 1990 | Piva, N; Cuneo, A; Carli, M G; Cariani, D; Fagioli, F; Castoldi, G | |
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation | 2009 | Deaglio S; Malavasi F | |
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET | 2016 | Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S | |
Chronic myeloid leukemia: Reminiscences and dreams | 2016 | Mughal, Tariq I.; Radich, Jerald P.; Deininger, Michael W.; Apperley, Jane F.; Hughes, Timothy P.; Harrison, Christine J.; Gambacorti-passerini, Carlo; Saglio, Giuseppe; Cortes, Jorge; Daley, George Q. | |
Chronic myeloid leukemia: Room for improvement? | 2017 | Baccarani, Michele; Pane, Fabrizio; Rosti, Gianantonio; Russo, Domenico; Saglio, Giuseppe | |
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib | 2012 | White DL; Radich J; Soverini S; Saunders VA; Frede AK; Dang P; Cilloni D; Lin P; Mongay L; Woodman R; Manley P; Slader C; Kim DW; Pane F; Martinelli G; Saglio G; Hughes TP. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile